|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1450 AUD | +7.41% |
|
+7.41% | -3.33% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 74.43 | - |
| Change | - | - | 343.99% | -38.27% | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 58.93 | 52.93 |
| Change | - | - | 241.42% | -36.44% | -10.18% |
| P/E | -2.64x | -3.27x | -14.3x | -5.87x | -22.5x |
| PBR | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.1x | 0.3x |
| Capitalization / Revenue | - | - | - | - | 7.44x |
| EV / Revenue | - | - | - | - | 5.29x |
| EV / EBITDA | - | - | -11.2x | -5.12x | -15.1x |
| EV / EBIT | - | - | -11.1x | -5.08x | -14.7x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.006 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 10 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -3.5 |
| EBIT 1 | - | - | -8.389 | -11.6 | -3.6 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -3.6 |
| Net Debt 1 | - | - | -27.85 | -15.5 | -21.5 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1350 | 0.1350 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - |
| Announcement Date | 30/05/23 | 30/05/25 | 29/05/26 | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.87x | - | -4.68x | - | 48.5M | |
| 21.75x | 6.73x | 14.72x | 1.46% | 57.82B | |
| 32.16x | 8.12x | 25.19x | 0.06% | 53.71B | |
| -43.06x | 13.69x | -40.15x | -.--% | 23.8B | |
| -18.33x | 4.37x | -7.66x | -.--% | 23.26B | |
| 25.89x | 5.11x | 13.48x | -.--% | 20.7B | |
| 24.77x | 4.84x | 15.78x | -.--% | 17.81B | |
| 50.68x | 20.65x | 53.17x | 0.07% | 16.9B | |
| -560.54x | 39.3x | -4381.59x | -.--% | 16.36B | |
| 17.45x | 5.07x | 11.8x | -.--% | 13.96B | |
| Average | -45.51x | 11.99x | -430.00x | 0.18% | 24.44B | |
| Weighted average by Cap. | -22.75x | 10.26x | -282.29x | 0.36% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
